Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Learn ways to combine income boosting with debt payoff strategies. Enhance your financial wellness effectively.
28,655 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Trump’s fury spain working as Washington weighs new trade moves against Madrid, drawing a sharp response from Spain a...
Two Nevada lawmakers demand a comprehensive plan to fix safety oversight gaps tied to Elon Musk's Boring Co. tunnelin...
Plug Power's Q1 2026 earnings call offers a window into a fast-evolving hydrogen economy. This guide breaks down reve...
When a big holder trims a stake in a robotics and AI ETF, it sparks questions about conviction and risk. This guide b...
Campbell’s posts worst quarters as revenue and margins deteriorate across key segments. The company trims full-year t...
LISC CEO Michael Pugh warns that housing costs outpace wages are widening the affordability gap. The charity-finance ...
Hearing aid costs top $7,000 for mid-range devices, and Original Medicare offers no coverage. The gap is reshaping se...
A freshly released financial disclosure lays out a multifaceted personal portfolio for the president, including more ...
New Delhi hosted a five-day AI summit that culminated in the New Delhi Declaration and a $200 billion investment pled...
Novo Nordisk stock faced renewed selling pressure this week as investors weighed trial results and government-driven ...
Rigetti Computing has dropped about 70% from its 52-week high. This article breaks down whether the dip offers real u...